Page last updated: 2024-12-10

uliginosin b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

uliginosin B: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5315118
CHEMBL ID464142
SCHEMBL ID3483228
SCHEMBL ID20301647
MeSH IDM0544610

Synonyms (18)

Synonym
10-00-4
4-[[5,7-dihydroxy-2,2-dimethyl-8-(2-methylpropanoyl)chromen-6-yl]methy l]-3,5-dihydroxy-6,6-dimethyl-2-(2-methylpropanoyl)cyclohexa-2,4-dien- 1-one
uliginosin b
CHEMBL464142
4-[[5,7-dihydroxy-2,2-dimethyl-8-(2-methylpropanoyl)chromen-6-yl]methyl]-3,5-dihydroxy-6,6-dimethyl-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one
ow8r9c8l96 ,
2-((5,7-dihydroxy-2,2-dimethyl-8-(2-methyl-1-oxopropyl)-2h-1-benzopyran-6-yl)methyl)-3,5-dihydroxy-4,4-dimethyl-6-(2-methyl-1-oxopropyl)-2,5-cyclohexadien-1-one
unii-ow8r9c8l96
2,5-cyclohexadien-1-one, 2-((5,7-dihydroxy-2,2-dimethyl-8-(2-methyl-1-oxopropyl)-2h-1-benzopyran-6-yl)methyl)-3,5-dihydroxy-4,4-dimethyl-6-(2-methyl-1-oxopropyl)-
19809-79-1
uliginosin b [mi]
SCHEMBL3483228
DTXSID90415684
SCHEMBL20301647
4-((5,7-dihydroxy-2,2-dimethyl-8-(2-methylpropanoyl)chromen-6-yl)methyl)-3,5-dihydroxy-6,6-dimethyl-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one
Q27285877
2-[[5,7-dihydroxy-8-(1-oxoisobutyl)-2,2-dimethyl-2h-1-benzopyran-6-yl]methyl]-3,5-dihydroxy-6-(1-oxo
4-[[5,7-dihydroxy-2,2-dimethyl-8-(2-methylpropanoyl)chromen-6-yl]methy l]-3,5-dihydroxy-6,6-dimethyl-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one

Research Excerpts

Overview

Uliginosin B is a natural phloroglucinol derivative, obtained from Hypericum species native to South America.

ExcerptReferenceRelevance
"Uliginosin B is a natural phloroglucinol derivative, obtained from Hypericum species native to South America. "( Determination of pharmacological interactions of uliginosin B, a natural phloroglucinol derivative, with amitriptyline, clonidine and morphine by isobolographic analysis.
Antonio, CB; da Costa, PF; Müller, LG; Noël, F; Rates, SM; Stolz, ED; von Poser, GL, 2014
)
2.1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID402010Antioxidant activity assessed as ABAP free radical scavenging measured by TRAP assay2005Journal of natural products, May, Volume: 68, Issue:5
Benzophenones from Hypericum carinatum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.69)29.6817
2010's11 (84.62)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.77 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.23 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]